Acute Porphyria Drug Database

A07DA05 - Loperamide Oxide
Propably not porphyrinogenic
PNP

Rationale
Less rapid systemic absorption as compared to loperamide. Possibly low systemic exposure. Probably CYP-metabolized. No data pointing to CYP-induction. Two references consider the substance (loperamide) generated in the intestines safe.
Chemical description
(To be edited, initial data ST OCT 04) Prodrug till loperamide, used in diarrhoea, 1 mg after each instance of defeacation. Converted to loperamide in the intestines through bacterial action. Systemic absorbtion of loperamide formed from loperamideoxide is 50% slower than that of the substance given perorally. Metabolized by oxidative demethylation. No data given on CYP-interaction, loperamide:Use/safe

Similar drugs
Explore alternative drugs in similar therapeutic classes A07D / A07DA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙